GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 785 filers reported holding GLAXOSMITHKLINE PLC in Q1 2018. The put-call ratio across all filers is 1.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $326,000 | -82.0% | 8,860 | -81.6% | 0.02% | -84.0% |
| Q3 2020 | $1,809,000 | -12.2% | 48,055 | -4.8% | 0.13% | -16.6% |
| Q2 2020 | $2,060,000 | +1.0% | 50,494 | -6.2% | 0.16% | -11.8% |
| Q1 2020 | $2,039,000 | -18.6% | 53,825 | +1.0% | 0.18% | +3.5% |
| Q4 2019 | $2,504,000 | +12.0% | 53,288 | +1.7% | 0.17% | +4.2% |
| Q3 2019 | $2,236,000 | +5.6% | 52,390 | -1.0% | 0.16% | +4.4% |
| Q2 2019 | $2,117,000 | +2.6% | 52,907 | +7.2% | 0.16% | +0.6% |
| Q1 2019 | $2,063,000 | +9.9% | 49,363 | +0.5% | 0.16% | -3.1% |
| Q4 2018 | $1,877,000 | +2.5% | 49,113 | +7.7% | 0.16% | +14.9% |
| Q3 2018 | $1,832,000 | +2.8% | 45,601 | +3.2% | 0.14% | -4.7% |
| Q2 2018 | $1,782,000 | +19.4% | 44,200 | +15.7% | 0.15% | +18.4% |
| Q1 2018 | $1,493,000 | +8.1% | 38,208 | -1.9% | 0.12% | +10.6% |
| Q4 2017 | $1,381,000 | -28.3% | 38,939 | -17.9% | 0.11% | -30.7% |
| Q3 2017 | $1,927,000 | -42.7% | 47,453 | -39.1% | 0.16% | -44.6% |
| Q2 2017 | $3,361,000 | -6.7% | 77,947 | -8.7% | 0.29% | -9.3% |
| Q1 2017 | $3,601,000 | -21.3% | 85,415 | -28.1% | 0.32% | -23.8% |
| Q4 2016 | $4,577,000 | -30.4% | 118,840 | -22.0% | 0.42% | -29.9% |
| Q3 2016 | $6,572,000 | -3.4% | 152,384 | -2.9% | 0.61% | -17.3% |
| Q2 2016 | $6,805,000 | +6.6% | 157,012 | -0.2% | 0.73% | +6.9% |
| Q1 2016 | $6,381,000 | -6.0% | 157,361 | -6.5% | 0.69% | -12.2% |
| Q4 2015 | $6,789,000 | +15.1% | 168,261 | +9.7% | 0.78% | +14.0% |
| Q3 2015 | $5,900,000 | -2.2% | 153,443 | +6.0% | 0.68% | +9.3% |
| Q2 2015 | $6,031,000 | -6.2% | 144,809 | +3.9% | 0.63% | 0.0% |
| Q1 2015 | $6,432,000 | +13.9% | 139,381 | +5.5% | 0.63% | +19.0% |
| Q4 2014 | $5,647,000 | -10.4% | 132,135 | -3.6% | 0.53% | -10.4% |
| Q3 2014 | $6,302,000 | -10.8% | 137,080 | +3.8% | 0.59% | -12.0% |
| Q2 2014 | $7,063,000 | +5.5% | 132,083 | +5.4% | 0.67% | 0.0% |
| Q1 2014 | $6,697,000 | +0.4% | 125,348 | +0.3% | 0.67% | -0.7% |
| Q4 2013 | $6,673,000 | +2.3% | 124,991 | -3.8% | 0.67% | -1.6% |
| Q3 2013 | $6,520,000 | -15.9% | 129,968 | -16.2% | 0.68% | -18.4% |
| Q2 2013 | $7,753,000 | – | 155,157 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |